APA aipamena

Kumar, B., Yadav, A., Brown, N. V., Zhao, S., Cipolla, M. J., Wakely, P. E., . . . Kumar, P. (2017). Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status. Oncotarget.

Chicago Style aipamena

Kumar, Bhavna, et al. "Nuclear PRMT5, Cyclin D1 and IL-6 Are Associated With Poor Outcome in Oropharyngeal Squamous Cell Carcinoma Patients and Is Inversely Associated With P16-status." Oncotarget 2017.

MLA aipamena

Kumar, Bhavna, et al. "Nuclear PRMT5, Cyclin D1 and IL-6 Are Associated With Poor Outcome in Oropharyngeal Squamous Cell Carcinoma Patients and Is Inversely Associated With P16-status." Oncotarget 2017.